- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Merck Launches Campaign to Support UK Carers
Merck, Darmstadt, Germany has announced that its Embracing Carers™ initiative has launched a new campaign to help individuals in the UK reflect and recognize their unpaid caring role sooner and access available support and resources faster. Developed by Merck, Darmstadt, Germany and guided by Carers UK and other leading international carer organizations, Embracing Carers™ is a global movement to highlight the important role of carers in society. With up to 6,000 people a day in the UK becoming carers, Embracing Carers has launched the “By Day, By Night initiative”. The campaign aims to help individuals reflect on their daily lives and help those in the UK recognize their role as a carer. 6.5 million people (around 10 per cent of the UK population) are carers and the majority take a long time to recognize their caring role. Research by Carers UK shows that over half (54%) of carers in the country took over a year to recognize their caring role and nearly a quarter (24%) took over five years to recognize their role as a carer.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
